Tech Company M&A Transactions
Sequenta Acquisition
Sequenta was bought by Adaptive Biotechnologies. The transaction was announced on 1/8/2015. The exit price for Sequenta was not provided.
Transaction Overview
Company Name
Acquired By
Announced On
1/8/2015
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
400 East Jamie Court 301
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Not Recorded
Overview
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Willis
Chief Scientific Officer
Malek Faham
Browse more venture capital transactions:
Prev: 1/7/2015: Appconomy venture capital transaction
Next: 1/8/2015: Vidcaster venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs